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Introduction
Chronic kidney disease (CKD) affects 10% of  the population of  Europe and the United States, and disease 
prevalence is increasing steadily. Renal interstitial fibrosis correlates well with kidney functional decline, 
and inhibition of  fibrosis is a promising strategy to slow down progression of  CKD. While it is well accept-
ed that myofibroblasts are the cells that cause fibrosis, the cellular origin of  kidney myofibroblasts is still 
very controversial (1–3). We have reported that approximately half  of  all kidney myofibroblasts are derived 
from the pericyte lineage (4). However, the origins of  the other half  remains unclear. A precise definition of  
the cellular origins of  kidney myofibroblasts represents a key step to understanding fibrosis and developing 
therapeutics to slow progression of  CKD.
The contribution of  proximal tubular epithelium to the myofibroblast pool via epithelial-to-mesen-
chymal transition has been controversial for almost 20 years and is ongoing (5–9). Genetic fate-tracing 
experiments have come to different conclusions, reporting no contribution (9), a major contribution (10), or 
a minor contribution of  the epithelium (11).
Similarly, the degree to which circulating progenitor cells contribute to the myofibroblast pool has 
also been debated for many years (2, 12, 13). Bone marrow–derived mesenchymal stem cells (MSCs) 
have been reported to contribute to as much as 35% of  the renal myofibroblast pool (11). Furthermore, 
fibrocytes and macrophages have also been defined as kidney myofibroblast progenitors. Fibrocytes were 
originally described more than two decades ago as a leukocyte-derived population of  fibroblast-like cells 
in subcutaneously implanted wound chambers that express extracellular matrix proteins, such as collagen 
I (14). Regarding a contribution of  fibrocytes to the myofibroblast pool in kidney fibrosis, studies from 
different groups have led to different conclusions. While bone marrow transplantation experiments using 
collagen 1a1 or collagen 1a2 reporter chimeras suggest no significant contribution of  circulating bone 
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marrow–derived cells to the myofibroblast pool (15, 16), other groups have reported a major contribution 
of  hematopoietic lineage-derived fibrocytes and macrophages to kidney fibrosis (17–24).
Most studies to date have relied heavily on confocal microscopy and/or bone marrow transplanta-
tion experiments. Discriminating myofibroblasts from hematopoietic lineage cells by confocal micros-
copy is technically challenging due to their thin, branched architecture and to their abundance in the 
renal interstitium after injury. Furthermore, bone marrow transplantation experiments using genetic 
reporters result in engraftment solely of  hematopoietic stem cells, whereas other bone marrow cells, 
such as MSCs, do not engraft well (4, 25), precluding analysis of  the contribution of  MSC lineage cells 
to the myofibroblast pool. Using an inducible genetic fate-tracing model, we confirmed that proximal 
tubular epithelium does not contribute to the myofibroblast pool. In order to dissect the contribution of  
any circulating cells to the renal myofibroblast pool, we have performed parabiosis and single-cell RNA 
sequencing (scRNA-seq) experiments. Our data indicate that monocytes contribute a small fraction of  
myofibroblasts in kidney fibrosis, whereas most myofibroblasts are derived from resident mesenchymal 
cells, such as pericytes and resident fibroblasts.
Results
Inducible genetic fate tracing indicates no contribution of  proximal tubular epithelium to the myofibroblast pool in 
kidney fibrosis. We recently developed an inducible and proximal tubule–specific Cre driver (26) by knocking 
a CreERt2 cassette into the sodium-dependent inorganic phosphate transporter SLC34a1 locus, which is 
expressed only in the proximal tubule. In order to perform inducible genetic fate tracing of  proximal tubu-
lar epithelium, we generated bigenic SLC34a1-GFPCreERt2; tdTomato mice (Figure 1A). Eight-week-old 
mice were pulsed with high-dose tamoxifen and subjected to unilateral ureteral obstruction (UUO) surgery 
at 10 days after the last tamoxifen dose (Figure 1B). Careful evaluation and quantification of  kidney sec-
tions costained for α-SMA indicated that proximal tubular epithelial cells do not become interstitial myofi-
broblasts (Figure 1, C and D).
Parabiosis model with fate tracing of  all cells from one mouse and kidney fibrosis induction in the other. To 
quantitate and better describe the contribution of  circulating cells to the kidney myofibroblast pool, 
we performed parabiosis experiments with generalized genetic cell fate tracing in one parabiont and 
induction of  kidney fibrosis in the other. To ubiquitously genetically label cells with the bright red fluoro-
chrome tdTomato, bigenic Rosa26CreER;tdTomato mice received tamoxifen and underwent parabiosis 
surgery at 10 days after the last tamoxifen dose (Figure 2A). The Rosa26CreER;tdTomato mice were 
conjoined with B6-CD45.1+ mice, which do not express tdTomato but express a different isoform of  the 
pan-leukocyte marker CD45, which can be discriminated by flow cytometry (B6-CD45.1+, as opposed to 
Rosa26CreER;tdTomato-CD45.2+) (Figure 2A). Shared circulation and recombination efficiency were 
verified 4 weeks after parabiosis surgery and before induction of  kidney fibrosis (Figure 2, B and C). The 
analysis showed a good cross-circulation, indicated by an almost 1:1 ratio of  CD45.1+ and CD45.2+ cells 
and a recombination efficiency of  >90% (Figure 2, B and C). The B6-CD45.1 parabiont was then subject-
ed to UUO surgery to assess whether any circulating tdTomato+ cells from the Rosa26CreER;tdTomato 
(CD45.2+) parabiont would contribute to the myofibroblast pool during kidney fibrosis. Mice were sacri-
ficed 10 days after UUO surgery. The contralateral noninjured kidney (CLK) served as an internal con-
trol. Development of  fibrosis in the UUO model was confirmed by trichrome staining and quantification 
(Supplemental Figure 1, A and B; supplemental material available online with this article; https://doi.
org/10.1172/jci.insight.99561DS1). Flow cytometric evaluation of  PBS-perfused spleens from CD45.1 
mice showed a cross-circulation with CD45.1+ and CD45.2+ leukocytes from both mice and confirmed 
efficient recombination (Figure 2, D and E). As expected, UUO surgery resulted in a tremendous influx 
of  leukocytes into the UUO kidneys. More than half  of  the leukocytes were derived from the CD45.2 
(Rosa26CreER;tdTomato) parabiont (Figure 2, F–H), confirming the effectiveness of  the cross-circula-
tion and an optimal experimental set up to study influx of  circulating cells from the conjoined mouse. 
Representative gating on living, single kidney cells is shown in Supplemental Figure 1C.
Circulating cells contribute to a minor fraction of  renal myofibroblasts. We next measured the contribution 
of  circulating cells (tdTomato+) to the myofibroblast lineage. Half  of  the fibrotic (UUO) and control 
(CLK) kidneys were subjected to flow cytometric evaluation and costaining with the myofibroblast marker 
α-smooth muscle actin (α-SMA). Flow cytometric evaluation after gating on single and living (DAPI–) cells 
indicated that, indeed, a small fraction of  renal myofibroblasts was derived from circulation (tdTomato+/α-
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SMA+) (Figure 3, A–F). While we observed a tremendous increase of  both tdTomato+ cells (influx of  all 
circulating cells) and α-SMA+ cells (expansion of  myofibroblasts) after UUO, as expected, only a small frac-
tion of  myofibroblasts coexpressed tdTomato, indicating that they originated from the Rosa26CreER;td-
Tomato parabiont (Figure 3, A–F). Confocal microscopy of  the Rosa26CreER;tdTomato (CD45.2) kidney 
confirmed the recombination efficiency and showed that all cells were tdTomato+ (Figure 3G).
To confirm the flow cytometric data, we used high-resolution confocal microscopy (Airyscan detector) 
to localize tdTomato+ myofibroblasts that were derived from circulation. While we only observed sparse 
tdTomato+ cells in the CLK kidneys of  the B6-CD45.1 parabiont, high-resolution confocal microscopy 
confirmed areas with large numbers of  tdTomato+ cells in the UUO kidneys. Importantly, we observed 
some tdTomato+ cells that indeed coexpressed perinuclear α-SMA (Figure 3H, arrows in UUO images), 
thus confirming the flow cytometric data with high-resolution imaging of  renal interstitium.
Flow cytometric analysis revealed that all cells in the UUO kidneys that were derived from circula-
tion (tdTomato+) also coexpressed CD45.2 (Figure 4, A and B) and, thus, were of  hematopoietic lineage. 
Indeed, costaining for CD45 with subsequent confocal microscopy showed that tdTomato+ cells in the 
kidneys showed a thin layer of  CD45 membrane staining, confirming their hematopoietic origin (Figure 4, 
C and D, insets). We next aimed to identify a combination of  surface markers that would allow isolation 
of  myofibroblasts from circulation in comparison to noncirculating myofibroblasts. As we have previous-
ly reported that all renal myofibroblasts coexpress the mesenchymal marker PDGFRβ (4) and PDGFRβ 
has also been described as a marker of  circulating fibrocytes (27), a combination of  PDGFRβ with CD45 
Figure 1. Inducible genetic fate tracing indicates no contribution of proximal tubular epithelium to kidney myofibroblasts. (A) Scheme of the 
generation of SCL34a1GFPCreERt2; tdTomato mice. (B) Scheme of the genetic fate-tracing experiment; 8-week-old SLC34a1GFPCreER;tdTomato mice 
(n = 3 males) were pulsed with tamoxifen (3 × 10 mg p.o.) and subjected to UUO surgery at 10 days after the last tamoxifen dose. Mice were sacrificed 
10 days after surgery. (C) Representative images of contralateral noninjured (CLK) and injured (unilateral ureteral obstruction [UUO]) kidneys stained 
for α-SMA. Original magnification, ×4 (first and third columns); ×60 (second and fourth columns). (D) Quantification of tdTomato+ and α-SMA+ versus 
α-SMA– cells. All data represent mean ± SD.
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would allow the isolation of  circulating hematopoietic myofibroblasts (PDGFRβ+CD45+) and resident 
nonhematopoietic (PDGFRβ+CD45–) cells. Indeed, costaining of  kidneys for PDGFRβ indicated that the 
tdTomato+/α-SMA+ population of  myofibroblasts derived from circulation coexpressed PDGFRβ (Figure 
3H). Thus, our data suggest that costaining for the pan-leukocyte marker CD45 and the mesenchymal 
marker PDGFRβ can be used to isolate both resident and circulating kidney myofibroblasts.
scRNA-seq confirms a contribution of  circulating CD45+ cells to the myofibroblast pool. We next turned to 
an unbiased nonparabiosis approach to confirm our genetic fate-tracing parabiosis results with scRNA-
seq from FACS isolated PDGFRβ+CD45+ and PDGFRβ+CD45– cells. C57BL/6 wild-type mice were 
subjected to UUO surgery and sacrificed 10 days after surgery. We sorted either myofibroblasts that were 
derived from circulation (PDGFRβ+CD45+) or all other myofibroblasts (PDGFRβ+CD45–) as singlets 
into individual wells of  96-well plates (Supplemental Figure 2A). We sorted two 96-well plates of  each 
population from whole digested UUO kidney samples and subjected the samples to scRNA-seq. The 
kidney samples were pooled from 3 different mice. Cells from 2 different plates were distributed even-
ly in the tSNE analysis clusters, excluding batch effects (Supplemental Figure 2B). The tSNE analysis 
resulted in 2 distinct clusters that were almost identical; the 2 sorted cell populations were made up of  
PDGFRβ+CD45+ and PDGFRβ+CD45– cells (Figure 5A). The top 30 upregulated genes in both clusters 
are outlined in Supplemental Figure 2C. Importantly, the scRNA-seq data confirmed the results of  the 
parabiosis fate-tracing experiment and demonstrated that the great majority of  myofibroblasts identified 
by expression of  α-SMA (Acta2) and or collagen (Col1a1, Col3a1) were among the PDGFRβ+CD45– 
population or resident kidney cells, whereas only a few myofibroblasts were among the population of  
Figure 2. Parabiosis with genetic fate tracing to 
dissect the contribution of circulating cells to kid-
ney fibrosis. (A) Rosa26CreER;tdTomato mice (n = 
8; all females, 8 week of age) received tamoxifen 
(4 × 10 mg p.o. every other day) to genetically tag 
all cells and were conjoined with B6.SJL (CD45.1) 
mice at 10 days after the last tamoxifen dose. 
Four weeks after parabiosis surgery the B6.SJL 
parabiont was subjected to unilateral ureteral 
obstruction (UUO) surgery to induce kidney fibro-
sis. Mice were sacrificed 10 days after UUO surgery. 
n = 2 mice died during the experiment; final data 
represent n = 6 parabiosis pairs in all readouts. MF, 
myofibroblast. (B) Representative flow cytometric 
plot and quantification of CD45.1+ versus CD45.2+ 
cells in the blood of the B6.SJL (CD45.1) parabiont 
at 4 weeks after parabiosis surgery. (C) Repre-
sentative flow cytometric plot and quantification 
of recombination efficiency (i.e., tdTomato+) of 
CD45.2+ cells in the blood of the B6.SJL parabiont 
at 4 weeks after parabiosis surgery. (D) Represen-
tative flow cytometric plots and quantification of 
CD45.1+ versus CD45.2+ cells in the spleen of the 
B6.SJL (CD45.1) parabiont after sacrifice. (E) Repre-
sentative flow cytometric plot and quantification 
of recombination efficiency (i.e., tdTomato+) of 
CD45.2+ cells in the spleen of the B6.SJL parabiont 
after sacrifice. (F–H) Representative flow cyto-
metric plots and quantification of CD45.1+ versus 
CD45.2+ leukocyte influx into the contralateral 
noninjured (CLK) and fibrotic UUO kidneys. All data 
represent mean ± SD. **P < 0.01 by unpaired t test; 
n = 6 in each graph.
5insight.jci.org   https://doi.org/10.1172/jci.insight.99561
R E S E A R C H  A R T I C L E
circulating hematopoietic PDGFRβ+CD45+ cells (Figure 5, B–E). The PDGFRβ+CD45– population 
showed expression of  markers that have been associated with pericytes and myofibroblasts, such as 
Timp1, Col1a1, Col3a1, Rgs5, desmin, CSPG4, and the mesenchymal marker vimentin (Figure 5, B–H, 
and Supplemental Figure 2C), whereas the population of  myofibroblasts derived from circulation (PDG-
FRβ+CD45+) showed high expression of  the monocyte marker CD68 (Figure 5I).
We next examined expression of  extracellular matrix proteins as well as chemokines and cytokines 
that have been associated with fibrosis. Interestingly the resident PDGFRβ+CD45– population showed 
strong expression of  various collagens and fibronectin, connective tissue growth factor (CTGF), and 
TGF-β3, whereas the circulating population of  PDGFRβ+CD45+ cells primarily expressed various 
Figure 3. A small fraction of kidney myofibroblasts is derived from circulation. (A) Flow cytometric plots of myofibroblasts (α-SMA+), circulating cells 
(tdTomato+), and α-SMA, tdTomato double-positive cells, i.e., myofibroblasts derived from circulation in noninjured contralateral kidneys (CLK) and 
fibrotic — unilateral ureteral obstruction (UUO) — kidneys from B6.SJL (CD45.1) mice (n = 6). (B) Fraction of circulating tdTomato+ cells from all kidney 
cells in CLK and fibrotic (UUO) kidneys from B6.SJL (CD45.1) mice (n = 6). (C) Fraction of myofibroblasts (α-SMA+) from all kidney cells in CLK and fibrotic 
(UUO) kidneys from B6.SJL (CD45.1) mice (n = 6). (D) Fraction of myofibroblasts derived from circulation (α-SMA+/tdTomato+) from all kidney cells in CLK 
and fibrotic (UUO) kidneys from B6.SJL (CD45.1) mice (n = 6). (E and F) Fraction of myofibroblasts derived from circulation (tdTomato+/α-SMA+) from all 
α-SMA+ myofibroblasts (n = 6). (G) Representative image of the noninjured kidney of the Rosa26CreER;tdTomato parabiont. Scale bars: 50 μm; 25 μm 
(inset). (H) High-resolution confocal microscopy (Airyscan) images of CLK and fibrotic (UUO) kidneys from B6.SJL (CD45.1) mice costained for α-SMA and 
PDGFRβ. Large arrows indicate tdTomato+ cells coexpressing α-SMA and PDGFRβ. Small arrows indicate the area of thin membranous PDGFRβ signal. 
Scale bars: 50 μm (column 1); 20 μm (columns 2–5); 10 μm (insets). All data represent mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 by unpaired t test.
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chemokines and interleukins with markedly lower or absent expression of  extracellular matrix com-
ponents compared with the population of  resident myofibroblasts (Figure 5J). These data indicate that 
circulating PDGFRβ+CD45+ cells only contributed a minor fraction to the myofibroblast pool but might 
regulate kidney fibrosis in a paracrine fashion by secretion of  proinflammatory and profibrotic chemo-
kines. We hypothesized therefore that circulating PDGFRβ+CD45+ cells might interact with resident 
PDGFRβ+CD45– cells and looked into receptor-ligand interactions between the 2 cell populations within 
the scRNA-seq data set. Interestingly, we observed strong expression of  multiple receptor-ligand pairs 
Figure 4. Myofibroblasts derived from circulation coexpress PDGFRβ and CD45. (A and B) Representative flow cytometric plot and quantification of 
tdTomato+ and CD45.2+ cells in blood, spleens, and UUO kidneys of the B6.SJL (CD45.1) mice (n = 6). (C) Representative high-resolution confocal microscopy 
images of contralateral noninjured kidney (CLK) and fibrotic unilateral ureteral obstruction (UUO) kidneys from B6.SJL (CD45.1) mice costained for α-SMA 
and CD45. Large arrows indicate tdTomato+ cells coexpressing α-SMA and CD45. Small arrows indicate the area of thin membranous CD45 signal. Scale 
bars: 50 μm (column 1); 20 μm (columns 2–5); 10 μm (insets). (D) Representative high-resolution confocal microscopy images of CLK and fibrotic UUO kid-
neys from B6.SJL (CD45.1) mice costained for PDGFRβ and CD45. All data represent mean ± SD; n = 6. Small arrows indicate the area of thin membranous 
CD45 and PDGFRβ signal in the tdTomato+ cell. Scale bars: 50 μm (column 1); 20 μm (columns 2–5).
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between both cell populations (Figure 5K). Among the observed ligands, we found CXCL4/PF4 expres-
sion in the circulating cells (PDGFRβ+CD45–), and we have recently reported that CXCL4 can induce 
myofibroblast differentiation in Gli1+ bone marrow cells (28). These data suggested that the circulating 
population might be involved in activation and myofibroblast differentiation of  the resident population 
of  myofibroblast precursors. We also checked the relative proliferative state of  the 2 populations based on 
the scRNA-seq data indicating that both populations have a high percentage of  cells in the G2/M and S 
phase of  the cell cycle and, thus, are cells that show a proliferative response to kidney injury (Figure 6A)
Figure 5. Single-cell RNA sequencing reveals that the majority of kidney myofibroblasts is derived from resident pericytes, while a small fraction 
is derived from circulation. (A) Single-cell RNA sequencing was performed on PDGFRβ+CD45– cells (myofibroblasts derived from circulation) and 
PDGFRβ+CD45+ cells (all other myofibroblasts) of whole fibrotic (unilateral ureteral obstruction [UUO]) kidneys. Kidneys were pooled from 3 mice, and 
two 96-well plates were sorted from each population. tSNE analysis clusters 2 distinct cell populations congruent with the sorted populations. (B–I) 
Expression levels of genes that define myofibroblasts, pericytes, or macrophages in both tSNE clusters (α-smooth muscle actin [Acta2]; collagen 
1 α 1 [Col1a1]; collagen 3 α 1 [Col3a1]). Color key denotes the Z-score normalized average expression value of selected differentially expressed genes 
between PDGFRβ+CD45– and PDGFRβ+CD45+ cells. (J) Expression levels of extracellular matrix components and proinflammatory, profibrotic cytokines 
and growth factors between the 2 cell populations. (K) Ligand-receptor pair expression according to cell type. Ligands are indicated on the right, 
receptors on the left. Lines indicate ligand-receptor pairs. Color key denotes the Z-score normalized average expression value.
8insight.jci.org   https://doi.org/10.1172/jci.insight.99561
R E S E A R C H  A R T I C L E
The circulating myofibroblasts are of  monocyte origin. Since transcription factors (TFs) drive cell identity, 
we next estimated TF activity based on their target gene (TG) expression in the scRNA-seq data. We 
aimed to identify key TFs that would define the 2 cell populations (Figure 6, B and C, and Supplemental 
Tables 1 and 2). The data showed 2 entirely distinct landscapes of  TF activity in the 2 cell populations, 
further indicating that the 2 cell populations of  resident (PDGFRβ+CD45–) and circulating myofibroblasts 
(PDGFRβ+CD45+) are distinct from each other. In line with their expression of  proinflammatory cyto-
kines and their hematopoietic origin from circulation, the analysis revealed TFs that have been reported 
to be critical in the inflammatory response and macrophage activation, such as ATF3 (29), Fos (30), Jun/
Junb (31), Maf  (32) and EGR1 (33) among others, were central in the landscape of  TF activity of  the 
PDGFRβ+CD45+ population (Figure 6, A and B, and Supplemental Table 1).
Figure 6. Single-cell RNA sequencing data identify circulating myofibroblast progenitors as monocytes. (A) Proliferative state in the 2 cell clusters based on 
gene expression. (B and C) Transcription factor (TF) activity network based on mRNA expression of TF target genes in the 2 cell populations. (D) Comparison 
of both cell populations with a Drop-Seq data set (10× genomics) of human peripheral blood mononuclear cells (n = 33,000 cells, healthy donor). The color key 
denotes the Pearson’s correlation coefficient (rho) between mouse and human cells. Rho has a value between –1 and 1. A greater rho value indicates higher 
correlation between the two cell types.
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In contrast, the resident population of  myofibroblasts (PDGFRβ+CD45–) was characterized by TFs 
that have been reported to define tissue-resident cardiac fibroblasts/myofibroblasts, such as Tcf21 (34), 
or MSCs, such as Prrx1 or Hoxd10 (35–37). Furthermore, the data suggested high activity of  the nuclear 
receptor subfamily 2 group member 2 (Nr2f2) in the resident PDGFRβ+CD45– population. Nr2f2 is an 
important inhibitor of  adipogenesis and has been recently reported to be highly expressed in Gremlin 1+ 
bone marrow MSCs (38). These findings are in line with our previously reported fate-tracing experiments 
that found that kidney Gli1+ pericytes represent a population of  MSCs and are a major source of  myo-
fibroblasts (4). We have further reported that Hedgehog/Gli signaling is a critical regulator of  Gli1+ cell 
expansion and that inhibition of  Gli proteins is a therapeutic strategy in kidney fibrosis (39). Consistent 
with these observations, the Hh pathway member and transcriptional repressor of  Hh signaling, Glis2, was 
among other TFs enriched in the PDGFRβ+CD45– population.
Gene ontology analysis revealed that genes involved in extracellular matrix formation, collagen pro-
duction, metabolism, and growth factor binding were substantially overrepresented in the resident myofi-
broblast population (PDGFRβ+CD45–), reflecting their major contribution to fibrosis formation (Supple-
mental Figure 3A). The circulating myofibroblast population of  PDGFRβ+CD45+ cells mostly showed 
expression of  genes that were associated with the immune response mechanism, reflecting their mechanism 
of  activation and homing to the injured kidney (Supplemental Figure 3).
We next asked which circulating blood population might give rise to the small kidney PDGFRβ+CD45+ 
myofibroblast population. We compared a published data set of  human peripheral blood mononuclear cells 
(PBMCs) to the resident (PDGFRβ+CD45–) and circulating (PDGFRβ+CD45+) kidney myofibroblast data 
set (Figure 6D). Importantly, we did not observe any overlap of  the PBMCs with the resident kidney myofi-
broblast population, whereas the circulating myofibroblast population of  PDGFRβ+CD45+ cells correlated 
strongly with human monocytes (Figure 6D). Altogether, these data indicate that circulating monocytes 
contribute a minor population of  myofibroblasts; while they do not secrete much extracellular matrix, 
they produce high amounts of  proinflammatory cytokines that might activate resident myofibroblasts. We 
next asked whether the circulating myofibroblast population of  PDGFRβ+CD45+ cells shows expression of  
genes that have been reported to characterize M1 or M2 macrophages. Interestingly, PDGFRβ+CD45+ cells 
primarily showed expression of  classically activated, proinflammatory M1 macrophages, such as Socs3, 
Tlr2, Il1b, TNFa, Ccl2, and Ccl8 (Supplemental Figure 3B).
Discussion
Our data indicate that proximal tubular epithelium does not contribute to the myofibroblast pool, whereas 
circulating monocytes contribute a minor population of  αSMA+ myofibroblasts. A contribution of  mono-
cytes and macrophages to the myofibroblast pool has been described by several groups (18, 23, 24, 40). 
However, Reich et al. have reported that fibrocytes independent of  monocyte lineages are an important 
source of  kidney myofibroblasts (17). As macrophages are a major site of  collagen internalization and 
degradation, antibody staining for matrix proteins might be difficult to interpret (2). Importantly, there is 
an ongoing debate as to whether there is a direct contribution of  myeloid leukocytes to the myofibroblast 
pool at all, and many reported effects might have been results of  indirect mechanisms (2, 41). Indeed, in 
this work, we show, using two powerful and complementary approaches, that a small percentage of  kid-
ney myofibroblasts derive from monocytes. However, importantly, these myeloid-derived myofibroblasts 
express very few matrix genes — suggesting they do not play a direct role in interstitial matrix accumu-
lation. The data indicate that PDGFRβ+CD45+ monocytes primarily secrete high amounts of  proinflam-
matory profibrotic cytokines that have been reported to activate resident myofibroblasts, suggesting para-
crine communications between circulating monocytes and resident myofibroblasts driving fibrosis as well. 
Thus, the direct contribution of  circulating monocytes to the myofibroblast pool and matrix production is 
minor compared with their paracrine effects. This scRNA-seq data set confirms that the great majority of  
kidney myofibroblasts are of  resident kidney origin.
A contribution of  circulating bone marrow MSCs to the kidney myofibroblast pool has been discussed 
for several years as well (11). After parabiosis, two mice share one blood circulation, which allows rapid 
exchange of  blood, cells, and particles, such as ultrasound bubbles, from one mouse to the other indepen-
dent of  cell size (42, 43). Therefore, our parabiosis approach, with induced labeling of  all cells (90% recom-
bination efficiency) in one mouse and induction of  kidney fibrosis in the other mouse, allows quantitative 
tracking of  all circulating cells, which would in theory also include MSCs. However, we found, through 
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two independent experiments, that only CD45+ and thus hematopoietic (nonmesenchymal) cells contribute 
a small population of  myofibroblast. Of  note, CD45 expression is an exclusion criterion for MSCs.
First, the parabiosis experiments demonstrate that circulating tdTomato+ cells in blood, spleen, and 
kidney are all CD45+, and all of  the circulating myofibroblasts we observed (tdTomato+/αSMA+) in the 
UUO kidneys also showed coexpression of  CD45. However, in the parabiosis experiments, our recombina-
tion efficiency was 90%, and, thus, although unlikely, we can not exclude that among the nonlabeled cells 
some nonhematopoietic cells might have contributed to the myofibroblast pool.
Second, since we have previously reported that all kidney myofibroblasts express PDGFRβ (4, 13), we 
performed nonbiased scRNA-seq of  PDGFRβ+ cells that were either CD45+ (hematopoietic) or CD45– 
(nonhematopoietic) to profile all kidney myofibroblasts. The data indicate that the vast majority of  kidney 
myofibroblasts are of  resident origin, while a minor fraction of  circulating hematopoietic (CD45+) cells also 
expressed the myofibroblast marker αSMA. Importantly, when comparing the data set to a human PBMC 
scRNA-seq data set, only the circulating (PDGFRβ+CD45+) population showed a strong correlation, and 
the comparison identified monocytes as the origin of  circulating myofibroblasts. Thus, our data indicate 
that circulating MSCs do not contribute to the myofibroblast pool.
Importantly, we have also recently reported bone marrow transplantation and parabiosis experiments, 
indicating that Gli1+ MSCs do not circulate (4), and a recent study reports no evidence for circulating 
MSCs in patients with organ injury, unless they suffer severe trauma with multiple fractures, which leads to 
mechanical disruption of  bone marrow with embolism (44). However, the scRNA-seq experiment was not 
performed as a time course, and thus we cannot account for dynamic changes in expression of  the markers 
over the course of  the experiment.
In conclusion, kidney myofibroblasts arise primarily from resident mesenchymal cells, whereas cir-
culating monocytes contribute a minor fraction. Importantly, these circulating myofibroblasts primarily 
secrete proinflammatory cytokines and do not appreciably contribute to extracellular matrix production.
Methods
Mice
Rosa26CreERt2 (JAX 008463), Rosa26tdTomato (JAX 007909), B6-CD45.1 (JAX 002014), and C57BL/6J 
(JAX 000664) mice were purchased from Jackson Laboratories. In the parabiosis experiment, bigenic Rosa-
26CreER;tdTomato mice (females, 8 weeks of  age) received tamoxifen (4 × 10 mg in corn oil with 3% eth-
anol ) per oral gavage (every other day) and were conjoined with B6-CD45.1 mice (8-week-old females) 10 
days after the last tamoxifen dose. Parabiosis was performed as previously described (45, 46).
Anesthesia was achieved by intraperitoneal injection of  ketamine (100 mg/kg bodyweight), xylazine 
(10 mg/kg), and acepromazine (3 mg/kg). Buprenorphine (0.05 mg/kg), meloxicam (1 mg/kg), and lido-
caine (1%) were given subcutaneously to achieve analgesia.
The entire flank of  each mouse was shaved, and the skin was cleaned with triple applications of  a 
povidone-iodine soap, alternating with an alcohol rinse. Thereafter, matching skin incisions were made 
from the elbow to the knee joint of  each mouse. The right olecranon of  one animal was attached to the left 
olecranon of  the other by a single 4-0 suture and tie. Similarly, the partners’ knee joints were connected. 
The dorsal and ventral skin was then anastomosed by staples and suture. Four weeks after parabiosis, sur-
gery blood was drawn from the retro-orbital vein plexus to check cross-circulation efficiency. Thereafter, 
the B6-CD45.1 mice underwent UUO surgery as follows. Anesthesia and analgesia was achieved in the 
parabiosis pair as described above. After flank incision, the right kidney was exposed and freed from the 
perirenal fat tissue and the ureter was tied off  at the level of  the lower pole using two 4.0 silk ties. Wounds 
were closed by staples. Mice were sacrificed at 10 days after UUO surgery. UUO surgeries in C57BL/6 
wild-type mice were performed at 8 weeks of  age using the same technique.
Tissue preparation and histology
Mice were anesthetized with isofluorane (Baxter) and subsequently perfused via the left ventricle with 4°C 
PBS for 1 minute. For histological analyses, tissue sections were fixed in 10% formaldehyde for 1 hour, paraf-
fin embedded, cut with a rotating microtome at a thickness of  3 μm, and stained according to routine histolog-
ical protocols. For immunofluorescence studies, kidneys were fixed in 4% paraformaldehyde on ice for 1 hour 
and then incubated in 30% sucrose in PBS at 4°C overnight. OCT-embedded (Sakura FineTek) tissues were 
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cryosectioned into 5-μm sections and mounted on Superfrost slides (Fisher Scientific). Sections were washed 
in 1× PBS, blocked in 10% normal goat serum (Vector Labs), and incubated with primary antibodies specific 
for α-SMA-FITC (mouse, 1:100, MilliporeSigma, catalog F3777), PDGFRb (rabbit, 1:100, Abcam, catalog 
ab32570), and CD45 (rat, 1:100, Novusbio, NB100-77417). Secondary antibodies were FITC- or Cy5-conju-
gated (Jackson ImmunoResearch). Sections were then stained with DAPI and mounted in Prolong Gold (Life 
Technologies). All images were obtained by confocal (Zeiss LSM880, equipped with an Airyscan detector) 
through the Washington University Center for Cellular Imaging. Fibrosis was scored at ×400 magnification 
using a counting grid with 117 intersections. The number of  grid intersections overlying trichrome-positive 
interstitial areas was counted and expressed as a percentage of  all grid intersections. Intersections that were in 
tubular lumen and glomeruli were subtracted from the total number of  grid intersections.
Flow cytometry and cell sorting
For flow cytometric analysis or FACS, mice were euthanized as described above and perfused with sterile 
PBS via the left ventricle, and the kidneys were placed in PBS with 5% FBS. After thoroughly mincing 
the tissue/organ using a sterile scalpel (Feather), the tissue/organ was placed in gentleMACS C Tubes 
(Miltenyi Biotec) containing 1.5 ml DMEM (Life Technologies) with 0.1 mg/ml Liberase TL (Roche). The 
tissue was then dissociated using the D program of  the gentleMacs dissociator (Miltenyi Biotec) followed 
by 30 minutes incubation at 37°C. Following washing steps with FACS buffer and centrifugation (300 g, 
5 minutes), the solution was filtered twice through a 40-μm cell strainer (BD Biosciences) and transfered 
to 5-ml Polystyrene Round-Bottom FACS tube (BD Biosciences). For flow cytometric studies, the samples 
were stained in 100–500 μl FACS buffer using the following fluorochrome-conjugated antibodies: CD45.1 
(APC-Cy7, ebioscience, 25045382), CD45.2-FITC (ebioscience, 110454), α-SMA-FITC (MilliporeSig-
ma, F3777), PDGFRb-APC (Biolegend, 136008), and CD45-BV421 (Biolegend, 103133) all 1:100 for 30 
minutes followed by a washing step with PBS. Cytofix/Cytoperm solution (BD Biosciences) was used to 
achieve staining for intracellular α-SMA. All flow cytometric analyses were performed with a Canto II 
analyzer (BD Biosciences). For sorting, DAPI (1 mg/ml, 1:1,000) was added in order to exclude dead cells. 
Single-cell sorting was performed at the Siteman Flow Cytometry Core (Washington University in St. Lou-
is) using an iCyt Synergy sorter (Sony). Single cells were sorted directly into 10× lysis buffer (Clontech) in 
96-well PCR plates. Data were analyzed by using Flow Jo software (version 9.6.2, Tree Star Inc.).
Single-cell RNA-sequencing and data preprocessing
96-well plates with single cell in each well were sealed and sent to the sequencing core at Washington 
University in St. Louis (Genome Technology Access Center). RNA from individual wells was processed 
with the Clonetech Smarter system and ligated with unique barcodes. Each plate was then pooled into one 
library, and the resulting pools were then ligated to adapters containing unique 7-bp index sequences, so 
that samples originating from a single plate can be identified by Illumina conventional indexing strategies 
and each individual well is defined by barcodes sequenced on the first read of  a paired end read pair.
All plates were pooled into a single library and subjected to Illumina sequencing (HiSeq2500, 2 × 50 bp). 
The resulting sequencing reads were demultiplexed by index with a custom Phython demultiplexing script 
and further demultiplexed by barcode with a custom Perl demultiplexing script. The RNA-sequencing reads 
were then aligned to the Mus musculus Ensembl release 76 top-level assembly with STAR version 3.0.4.b. 
Gene counts were derived from the number of  uniquely aligned unambiguous reads by Subread:feature-
Count version 1.4.5. Sailfish version 0.6.3 was used to produce isoform estimated counts. Gene and isoform 
counts were further transformed into counts per million (CPM), using log2 CPM with a prior count of  2 
(moderated log2CPM), and RPKM with custom Rscripts. Sequencing performance was assessed for the total 
number of  aligned reads, the total number of  uniquely aligned reads, the genes and transcripts detected, the 
ribosomal fraction, the known junction saturation, and the read distribution over known gene models with 
RSeQC version 2.3. The single-cell RNA-sequencing raw data are available in the Gene Expression Omni-
bus database (accession GSE112033).
Bioinformatics
Unsupervised clustering and differential gene analysis. We used Seurat software in R to identify cell clusters, 
performed differential gene analysis, and generated the top gene heatmap. In brief, a gene expression matrix 
with gene names as rows and cell names as columns was input into Seurat. Before clustering, we removed 
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genes with low expression levels and low-quality cells by filtering out genes that were expressed in less than 
10 cells and cells that had a greater than 20% mitochondrial gene content, resulting in 14,062 genes and 
357 cells. After filtering, we normalized the expression values for each cell by the total expression, multi-
plied this by 10,000, and log transformed the result. Next, we performed dimensionality reduction on the 
scaled data by computing the significant principal components (PCs) on highly variable genes. Graph-based 
clustering analyses were performed on the first 10 PCs, and clusters were visualized in tSNE. To examine 
potential batch effect, cells were colored by plates and plotted in the same tSNE. Differential gene analysis 
was performed using the FindAllMarkers function in Seurat (likelihood-ratio test). Differentially expressed 
genes that were expressed at least in 25% cells within the cluster and with a fold change of  more than 0.25 
(log scale) were considered to be marker genes. Marker genes in each cluster were visualized by two differ-
ent ways: we used the DoHeatmap function (Seurat) to show the top 30 genes for each cluster and the Fea-
turePlot function (Seurat) to plot the well-known markers. To compare the relative expression of  profibrotic 
genes and proinflammatory genes between clusters, we selected genes that are components of  extracellular 
matrix and genes that are known as cytokines/chemokines from the differential gene list. The average 
expression level of  these selected genes was Z-score normalized and visualized using the pheatmap package 
in R. To classify the gene function of  the marker genes, we uploaded the differential gene list onto Top-
pGene suite (https://toppgene.cchmc.org) for gene set functional enrichment analysis. The top 5 enriched 
gene ontology terms from each category (molecular function, cellular components, and biological function) 
were compared among clusters, and bar graphs shown in figures were generated using the ggplot2 package.
Comparison of  fibrocytes and a public PBMC data set. Cell-type–specific expression patterns of  the cell 
clusters identified in our data set were compared with signatures previously defined in a PBMC data 
set by calculating the pairwise Pearson correlations coefficients between each pair of  cell types for the 
same set of  genes. First, a precomputed Seurat object containing cell cluster information for 33,000 
human PBMCs was downloaded from Satija Lab (http://satijalab.org/seurat/get_started.html). Sec-
ond, mouse genes were converted to human equivalent genes using a R package biomaRt. Only genes 
that are detected in our data set and the PBMC data set were used for downstream correlation analysis. 
Third, Pearson correlation was computed between the cell clusters in our data set and the cell clusters 
identified in the PBMC data set, using the previously defined cell-type annotations and normalized 
average gene expression values for each cell type. Data were shown by pheatmap R package.
Construction of  transcription network by driving force analysis. To identify the key regulators that control the 
cell states, we established the relationship between TFs and their TGs following the SINCERA pipeline (47). 
This approach consists of  three main steps. First, the candidate TFs and TGs were extracted from the DEG 
list identified in each cluster. Second, cell-type–specific transcription regulatory network (TRN) was con-
structed by establishing the interaction between TF-TF and TF-TG as previously described (48). TG-TF and 
TF autoregulations were not considered in the present study. Finally, the key TFs were selected based on their 
network node importance and ranked by integrating 6 node importance metrics, including degree centrality, 
closeness centrality, betweenness centrality, disruptive fragmentation centrality, disruptive connection cen-
trality, and disruptive distance centrality. The TRN igraph object obtained from SINCERA was converted to 
JSON using a R package RJSONIO and imported into Cytoscape (version 3.4.0) for network visualization.
Ligand-receptor interaction analysis
To study ligand-receptor interactions between myofibroblast and fibrocyte, we used a human ligand-re-
ceptor list comprising 2,557 ligand-receptor pairs curated by the Database of  Ligand-Recetor Partners, 
IUPHAR, and Human Plasma Membrane Receptome (49). We selected the receptors that were only dif-
ferentially expressed in each cell type. To determine the ligand-receptor pairs to plot on the heatmap, we 
required that (a) the receptors are uniquely expressed in each cell type (q < 0.05 and log fold change > 0.6) 
and (b) each receptor should have at least one corresponding ligand to pair with. We used heatmap.2 func-
tion from gplots package to visualize the ligand-receptor pairs.
Statistics
Data are presented as mean ± SD. Comparison of  two groups was performed using unpaired 2-tailed t 
test. Paired 2-tailed t test was used for comparison of  repeated measured in the same group. Statistical 
analyses were performed using GraphPad Prism 5.0c (GraphPad Software Inc.). A P value of  less than 
0.05 was considered significant.
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